Seattle Genetics, Inc.
Seattle Genetics to Present SGN-35 and Lintuzumab Clinical Data at the European Hematology Association Congress
Published in Drug Law Weekly, June 9th, 2009
“In our SGN-35 presentation at EHA, we will provide additional data on durability of response and progression-free survival of patients in our every three week dosing study,” said Thomas C. Reynolds, M.D., Ph.D., Chief Medical Officer of Seattle Genetics. “In addition, we will report a strong...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-09)
More Articles from Drug Law Weekly
- Addiction Medicine
New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction - Adverse Drug Reactions
Researchers from Teikyo University, Medical Department discuss findings in adverse drug reactions - Angiology
New findings reported from S.S. Agarwal and co-authors describe advances in angiology - Bureau of Alcohol, Tobacco, Firearms and Explosives
Two Subjects Arrested for Solicitation to Commit Capital Murder - Burke, Mahoney & Wise
$12 Million Settlement in Birth Injury Lawsuit Against OSF Healthcare, Announces Burke, Mahoney & Wise - Campaign for Tobacco-Free Kids
New Maine Poll: Voters Strongly Support FDA Regulation of Tobacco Products - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
